Literature DB >> 30600947

Frequency and Implications of Natural Killer and Natural Killer T Cells in Hepatocellular Carcinoma.

Asmaa M Zahran1, Mona M Abdel-Meguid2, Ahmed M Ashmawy3, Amal Rayan4, Azza Elkady5, Nahla M Elsherbiny6, Helal F Hetta6.   

Abstract

A complex role of the immune system has been highlighted in the development and progression of hepatocellular carcinoma (HCC). Natural Killer cells (NK) and natural killer T cells (NKT) cells are among the innate immune lymphocytes that predominate in the liver and can prevent tumor growth and metastasis. The aim of the study was to measure the percentages of NK and NKT cells among a sample of Egyptian patients with HCC and to find the association between their frequencies and disease progression. The study included 2 groups; the HCC patient group (n=40) and the healthy control group (n=20). Blood samples were drawn from all subjects for complete blood picture, liver enzymes and alpha fetoprotein serum level measurement. Flow cytometric analysis was performed for CD3 and CD16/56 for determining the percentages of NK and NKT cells. The frequencies of NK cells and NKT cells were significantly decreased in HCC patients (6.58± 1.76 and 5.26 ± 1.13 respectively) as compared to healthy controls (9.01±1.62 and 6.88 ± 1.88 respectively) (P < 0.001 and 0.0008 respectively) and in HCC patients with metastasis (6.01± 1.11 and 5.07± 1.10 respectively) than HCC patients without metastasis (7.75± 1.98 and 5.89± 0.88 respectively) (P= 0.004 and 0.03 respectively). We concluded that the reduced percentages of NK cells and NKT cells in HCC patients especially in those with metastasis point to their important roles in the occurrence and progression of HCC. Copyright© by the Egyptian Association of Immunologists.

Entities:  

Mesh:

Year:  2018        PMID: 30600947

Source DB:  PubMed          Journal:  Egypt J Immunol


  5 in total

1.  Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma.

Authors:  Asmaa M Zahran; Zeinab Albadry M Zahran; Omnia El-Badawy; Mona H Abdel-Rahim; Wageeh A M Ali; Amal Rayan; Muhammad Abbas El-Masry; Mohamed A A Abozaid; Helal F Hetta
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

2.  Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes.

Authors:  Asmaa M Zahran; Helal F Hetta; Amal Rayan; Abeer Sharaf Eldin; Elham Ahmed Hassan; Hussein Fakhry; Ahmed Soliman; Omnia El-Badawy
Journal:  Cancer Immunol Immunother       Date:  2020-03-13       Impact factor: 6.968

Review 3.  Cytotoxic Chemotherapy as an Alternative for Systemic Treatment of Advanced Hepatocellular Carcinoma in Developing Countries.

Authors:  Khaled Abouelezz; Dipen Khanapara; Gaber El-Saber Batiha; Esraa A Ahmed; Helal F Hetta
Journal:  Cancer Manag Res       Date:  2020-11-27       Impact factor: 3.989

4.  Association between interleukin 6 polymorphisms (rs1800796, rs1800795, rs2069837, rs17147230, and rs1800797) and hepatocellular carcinoma susceptibility: a meta-analysis.

Authors:  Omid Emami Aleagha; Pembe Oltulu; Masoud Sadeghi
Journal:  Clin Exp Hepatol       Date:  2020-12-30

5.  Regulatory T cell and activated natural killer cell infiltration in hepatocellular carcinoma: immune cell profiling using the CIBERSORT.

Authors:  Lixin Wang; Zongguo Yang; Yajuan Cao
Journal:  Ann Transl Med       Date:  2020-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.